Commentary on Krans et al.: Outcomes associated with the use of medications for opioid use disorder during pregnancy

Saved in:
Bibliographic Details
Published in:Addiction (Abingdon, England) England), 2022-06, Vol.117 (6), p.1818-1819
Main Author: Schmidt, Rose A.
Format: Article
Language:English
Subjects:
Buprenorphine - therapeutic use
comment
Drug abuse
Drug addiction
epidemiology
Female
Humans
Medication for opioid use disorder
Opioid-Related Disorders - drug therapy
Opioids
postpartum
Pregnancy
Substance use disorder
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3530-891736b41850e3af9966a7bc861f6f5d1f35fae725a0e3f200a079e06318d8053
cites cdi_FETCH-LOGICAL-c3530-891736b41850e3af9966a7bc861f6f5d1f35fae725a0e3f200a079e06318d8053
container_end_page 1819
container_issue 6
container_start_page 1818
container_title Addiction (Abingdon, England)
container_volume 117
creator Schmidt, Rose A.
description
doi_str_mv 10.1111/add.15830
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2659968098</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2659968098</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3530-891736b41850e3af9966a7bc861f6f5d1f35fae725a0e3f200a079e06318d8053</originalsourceid><addsrcrecordid>eNp1kE1PwyAYgInR6Jwe_AOGxJOHbi-lUOrNzM-4ZBc9N6yAYtZSgWbZvxetepMLh_fhIe-D0BmBGUlnLpWaESYo7KEJoRwyKAq6jyZQcZblpIAjdBzCOwCUoioO0RFlJK_yXExQXLi21V2Ufoddh5-87ALWEcvN7Aqvhti4VgcsQ3CNlVErvLXxDcc3jYegsTO41co2MlqX3hnnseuts-p7qmxwXmmP1eBt94p7r1872TW7E3Rg5Cbo0597il7ubp8XD9lydf-4uF5mDWUUMlGRkvJ1QQQDTaWpKs5luW4EJ4YbpoihzEhd5kymuckBJJSVBk6JUAIYnaKL0dt79zHoEOt3N_gufVnnnCWdgEok6nKkGu9C8NrUvbdtClITqL_61qlv_d03sec_xmGdNv8jf4MmYD4CW7vRu_9N9fXNzaj8BIzJg_U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2659968098</pqid></control><display><type>article</type><title>Commentary on Krans et al.: Outcomes associated with the use of medications for opioid use disorder during pregnancy</title><source>International Bibliography of the Social Sciences (IBSS)</source><source>EBSCOhost SPORTDiscus with Full Text</source><source>Wiley</source><creator>Schmidt, Rose A.</creator><creatorcontrib>Schmidt, Rose A.</creatorcontrib><identifier>ISSN: 0965-2140</identifier><identifier>EISSN: 1360-0443</identifier><identifier>DOI: 10.1111/add.15830</identifier><identifier>PMID: 35129228</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Buprenorphine - therapeutic use ; comment ; Drug abuse ; Drug addiction ; epidemiology ; Female ; Humans ; Medication for opioid use disorder ; Opioid-Related Disorders - drug therapy ; Opioids ; postpartum ; Pregnancy ; Substance use disorder</subject><ispartof>Addiction (Abingdon, England), 2022-06, Vol.117 (6), p.1818-1819</ispartof><rights>2022 Society for the Study of Addiction</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3530-891736b41850e3af9966a7bc861f6f5d1f35fae725a0e3f200a079e06318d8053</citedby><cites>FETCH-LOGICAL-c3530-891736b41850e3af9966a7bc861f6f5d1f35fae725a0e3f200a079e06318d8053</cites><orcidid>0000-0002-0307-8482</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,33223</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35129228$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schmidt, Rose A.</creatorcontrib><title>Commentary on Krans et al.: Outcomes associated with the use of medications for opioid use disorder during pregnancy</title><title>Addiction (Abingdon, England)</title><addtitle>Addiction</addtitle><subject>Buprenorphine - therapeutic use</subject><subject>comment</subject><subject>Drug abuse</subject><subject>Drug addiction</subject><subject>epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Medication for opioid use disorder</subject><subject>Opioid-Related Disorders - drug therapy</subject><subject>Opioids</subject><subject>postpartum</subject><subject>Pregnancy</subject><subject>Substance use disorder</subject><issn>0965-2140</issn><issn>1360-0443</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>8BJ</sourceid><recordid>eNp1kE1PwyAYgInR6Jwe_AOGxJOHbi-lUOrNzM-4ZBc9N6yAYtZSgWbZvxetepMLh_fhIe-D0BmBGUlnLpWaESYo7KEJoRwyKAq6jyZQcZblpIAjdBzCOwCUoioO0RFlJK_yXExQXLi21V2Ufoddh5-87ALWEcvN7Aqvhti4VgcsQ3CNlVErvLXxDcc3jYegsTO41co2MlqX3hnnseuts-p7qmxwXmmP1eBt94p7r1872TW7E3Rg5Cbo0597il7ubp8XD9lydf-4uF5mDWUUMlGRkvJ1QQQDTaWpKs5luW4EJ4YbpoihzEhd5kymuckBJJSVBk6JUAIYnaKL0dt79zHoEOt3N_gufVnnnCWdgEok6nKkGu9C8NrUvbdtClITqL_61qlv_d03sec_xmGdNv8jf4MmYD4CW7vRu_9N9fXNzaj8BIzJg_U</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Schmidt, Rose A.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope><scope>8BJ</scope><scope>FQK</scope><scope>JBE</scope><scope>K9.</scope><scope>NAPCQ</scope><orcidid>https://orcid.org/0000-0002-0307-8482</orcidid></search><sort><creationdate>202206</creationdate><title>Commentary on Krans et al.: Outcomes associated with the use of medications for opioid use disorder during pregnancy</title><author>Schmidt, Rose A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3530-891736b41850e3af9966a7bc861f6f5d1f35fae725a0e3f200a079e06318d8053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Buprenorphine - therapeutic use</topic><topic>comment</topic><topic>Drug abuse</topic><topic>Drug addiction</topic><topic>epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Medication for opioid use disorder</topic><topic>Opioid-Related Disorders - drug therapy</topic><topic>Opioids</topic><topic>postpartum</topic><topic>Pregnancy</topic><topic>Substance use disorder</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schmidt, Rose A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Addiction (Abingdon, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schmidt, Rose A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Commentary on Krans et al.: Outcomes associated with the use of medications for opioid use disorder during pregnancy</atitle><jtitle>Addiction (Abingdon, England)</jtitle><addtitle>Addiction</addtitle><date>2022-06</date><risdate>2022</risdate><volume>117</volume><issue>6</issue><spage>1818</spage><epage>1819</epage><pages>1818-1819</pages><issn>0965-2140</issn><eissn>1360-0443</eissn><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>35129228</pmid><doi>10.1111/add.15830</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-0307-8482</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0965-2140
ispartof Addiction (Abingdon, England), 2022-06, Vol.117 (6), p.1818-1819
issn 0965-2140
1360-0443
language eng
recordid cdi_proquest_journals_2659968098
source International Bibliography of the Social Sciences (IBSS); EBSCOhost SPORTDiscus with Full Text; Wiley
subjects Buprenorphine - therapeutic use
comment
Drug abuse
Drug addiction
epidemiology
Female
Humans
Medication for opioid use disorder
Opioid-Related Disorders - drug therapy
Opioids
postpartum
Pregnancy
Substance use disorder
title Commentary on Krans et al.: Outcomes associated with the use of medications for opioid use disorder during pregnancy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T10%3A42%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Commentary%20on%20Krans%20et%20al.:%20Outcomes%20associated%20with%20the%20use%20of%20medications%20for%20opioid%20use%20disorder%20during%20pregnancy&rft.jtitle=Addiction%20(Abingdon,%20England)&rft.au=Schmidt,%20Rose%20A.&rft.date=2022-06&rft.volume=117&rft.issue=6&rft.spage=1818&rft.epage=1819&rft.pages=1818-1819&rft.issn=0965-2140&rft.eissn=1360-0443&rft_id=info:doi/10.1111/add.15830&rft_dat=%3Cproquest_cross%3E2659968098%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3530-891736b41850e3af9966a7bc861f6f5d1f35fae725a0e3f200a079e06318d8053%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2659968098&rft_id=info:pmid/35129228&rfr_iscdi=true